Pfizer tests promising new shot to stop lyme disease
NCT ID NCT07226882
Summary
This study is testing a new vaccine, called VLA15, designed to prevent Lyme disease. It will enroll 200 healthy adults aged 18-44 to see how safe the vaccine is and how well it triggers an immune response when given on different schedules. Participants will receive four vaccine shots and one placebo shot over about two years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYME DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amherst Family Practice, P.C.
NOT_YET_RECRUITINGWinchester, Virginia, 22601, United States
-
Clinical Research Partners, LLC
NOT_YET_RECRUITINGRichmond, Virginia, 23226, United States
-
Preferred Primary Care Physicians
RECRUITINGUniontown, Pennsylvania, 15401, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)
NOT_YET_RECRUITINGPittsburgh, Pennsylvania, 15236, United States
-
Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair
RECRUITINGPittsburgh, Pennsylvania, 15243, United States
Conditions
Explore the condition pages connected to this study.